Atea Pharmaceuticals Inc. (AVIR), a clinical-stage biopharmaceutical company developing oral antiviral therapeutics for serious viral diseases, has an upcoming clinical trial event next month that is worth keeping an eye on.
The first interim analysis of the company's SUNRISE-3 trial by an independent Data Safety Monitoring Board (DSMB) for safety and futility is expected this March.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.